Kintz Samuel Insider Trading Activity
Kintz Samuel has been net-selling over the last 12 months with 0 purchases and 8 sales across 1 company.
ELVN is the most-traded position with 8 trades. The largest single transaction was a sale of ELVN for $273K on Nov 17, 2025.
Performance Scorecard
Forward stock performance after each transaction by Kintz Samuel. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +1.8% | 43% | 14 |
| 90 days | — | +3.2% | 57% | 14 |
| 120 days | — | -9.4% | 50% | 14 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersELVN · Enliven Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Kintz Samuel bought and sold ELVN.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Nov 17, 2025 | ELVN | Sell | 12,500 | $21.82 | $273K | −1.4% | CEO | |
Oct 17, 2025 | ELVN | Sell | 12,500 | $21.33 | $267K | −1.4% | CEO | |
Sep 26, 2025 | ELVN | Sell | 3,700 | $20.06 | $74K | −0.4% | CEO | |
Sep 23, 2025 | ELVN | Sell | 2,800 | $20.03 | $56K | −0.3% | CEO | |
Sep 19, 2025 | ELVN | Sell | 1,000 | $20.25 | $20K | −0.1% | CEO | |
Sep 17, 2025 | ELVN | Sell | 5,000 | $19.09 | $95K | −0.5% | CEO | |
Aug 19, 2025 | ELVN | Sell | 590 | $20.00 | $12K | −0.1% | CEO | |
Aug 18, 2025 | ELVN | Sell | 10,393 | $20.02 | $208K | −1.1% | CEO | |
Jul 17, 2025 | ELVN | Sell | 4,150 | $21.58 | $90K | −0.4% | CEO | |
Jul 17, 2025 | ELVN | Sell | 4,687 | $22.69 | $106K | −0.5% | CEO | |
Jul 17, 2025 | ELVN | Sell | 3,663 | $23.37 | $86K | −0.4% | CEO | |
Jun 17, 2025 | ELVN | Sell | 10,502 | $22.08 | $232K | −1.1% | CEO | |
Jun 17, 2025 | ELVN | Sell | 1,998 | $22.75 | $45K | −0.2% | CEO | |
Jun 3, 2025 | ELVN | Sell | 7,500 | $20.05 | $150K | −0.8% | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | 14 | $1.7M |
Other insiders at Enliven Therapeutics, Inc.
5 other tracked filers at ELVN.